HKR INT'L (00480): Deng Manhua resigned as Executive Director, Managing Director, and Authorized Representative.
Hong Kong Xingye International (00480) announced that Mr. Deng Manhua will resign from his position as Executive Director, Managing Director, and Authorized Representative of the company effective September 16, 2026, due to having reached retirement age and wishing to devote more time to personal interests and affairs.
HKR INT'L (00480) announced that Mr. Deng Manhua will step down from his positions as Executive Director, Managing Director, and Authorized Representative of the company effective September 16, 2026, as he has reached retirement age and wishes to devote more time to his personal interests and affairs.
Following Mr. Dengs departure, the current Executive Chairman, Mr. Cha Maocheng, will temporarily assume the roles and responsibilities of Managing Director starting from September 16, 2026, until a suitable long-term replacement is found.
Related Articles
YAN PALACE (01497) repurchased 70,000 shares at a cost of HKD 424,800 on August 25.
CHINA CHENGTONG (00217) announced a positive profit forecast, expecting a shareholder's profit of approximately HKD 43.8 million for the first half of the year, a significant increase of about 343% year-on-year.
INNOVENT BIO (01801) released its interim results, with a profit of 1.253 billion yuan, a year-on-year increase of 50.2%.
YAN PALACE (01497) repurchased 70,000 shares at a cost of HKD 424,800 on August 25.
CHINA CHENGTONG (00217) announced a positive profit forecast, expecting a shareholder's profit of approximately HKD 43.8 million for the first half of the year, a significant increase of about 343% year-on-year.
INNOVENT BIO (01801) released its interim results, with a profit of 1.253 billion yuan, a year-on-year increase of 50.2%.
RECOMMEND
